Newsletter May 2024 No.221
Top News
The 35th JPMA Policy Seminar" was held on March 4, 2024. While drug prices are under intense scrutiny in order to curb rising social security costs, healthcare policy is being challenged by the introduction of a succession of highly effective but expensive biopharmaceuticals. At the same time, there is a growing need for a mechanism to efficiently produce such innovative drugs in Japan. At this policy seminar, through lectures and panel discussions by experts from various fields, many proposals were made on how to balance the maintenance of the universal health insurance system and the enhancement of drug discovery in order to provide sustainable health care to the people. The following is a transcript of the seminar.
Topics
- Educational event on pharmaceutical and medical issues "Living with Disease. Living with Hope. Photo Exhibition" was held.
- Meeting of Compliance Managers and Practitioners for FY2023
- JPMA Media Forum" Held Considering the Diverse Values that Pharmaceuticals Bring - For the Rich Everyday Life that Patients and Their Families Desire
- The First Neglected Tropical Diseases Student Contest and Online Event on World NTD Day 2024
- 2024 Life Science Intellectual Property Forum" Held Now is the Time to Strengthen Japan's Drug Discovery Capability! ～Aiming to Build a Robust Drug Discovery Ecosystem for New Modalities
- The 10th Japan-Thailand Joint Symposium" was held.
- Briefing on the Revision of the Cost-Effectiveness Evaluation System in Fiscal 2024
Policy Research Institute
The Current State of Japanese Academia from the Perspective of Research Power
From JPMA
Toward Building a Drug Discovery Ecosystem Suitable for Japan